BrainAurora Medical Technology Launches HK$583 Million Hong Kong IPO

MT Newswires Live2024-12-30

BrainAurora Medical Technology (HKG:6681) launched its HK$583.2 million initial public offering in Hong Kong on Monday.

The digital diagnostics and therapies provider is offering 181,112,000 shares at HK$3.22 apiece.

BrainAurora secured four cornerstone investors, including Tasly Pharmaceuticals (SHA:600535), which committed to subscribe to $48.5 million worth of IPO shares.

The issuer expects to disclose the allocations on Jan. 7. It will start trading on the Hong Kong bourse on Jan. 8, according to a Monday filing.

Deal proceeds will be used for research and development, clinical trials, technology upgrades, new cognitive centers, and working capital.

CICC, SPDB International, CMBC International, Fosun International, GF Securities, and several others are the joint book-runners of the IPO.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment